These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 26345850)

  • 1. Impairment of protein trafficking upon overexpression and mutation of optineurin.
    Park B; Ying H; Shen X; Park JS; Qiu Y; Shyam R; Yue BY
    PLoS One; 2010 Jul; 5(7):e11547. PubMed ID: 20634958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oligomerization of optineurin and its oxidative stress- or E50K mutation-driven covalent cross-linking: possible relationship with glaucoma pathology.
    Gao J; Ohtsubo M; Hotta Y; Minoshima S
    PLoS One; 2014; 9(7):e101206. PubMed ID: 24983867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astrocytes modulate neurodegenerative phenotypes associated with glaucoma in OPTN(E50K) human stem cell-derived retinal ganglion cells.
    Gomes C; VanderWall KB; Pan Y; Lu X; Lavekar SS; Huang KC; Fligor CM; Harkin J; Zhang C; Cummins TR; Meyer JS
    Stem Cell Reports; 2022 Jul; 17(7):1636-1649. PubMed ID: 35714595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Glaucoma-Associated Variant of Optineurin, M98K, Activates Tbk1 to Enhance Autophagosome Formation and Retinal Cell Death Dependent on Ser177 Phosphorylation of Optineurin.
    Sirohi K; Kumari A; Radha V; Swarup G
    PLoS One; 2015; 10(9):e0138289. PubMed ID: 26376340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulatory and Antioxidant Drugs in Glaucoma Treatment.
    Buonfiglio F; Pfeiffer N; Gericke A
    Pharmaceuticals (Basel); 2023 Aug; 16(9):. PubMed ID: 37765001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glaucoma, Stem Cells, and Gene Therapy: Where Are We Now?
    Daliri K; Ljubimov AV; Hekmatimoghaddam S
    Int J Stem Cells; 2017 Nov; 10(2):119-128. PubMed ID: 28844129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered Functions and Interactions of Glaucoma-Associated Mutants of Optineurin.
    Swarup G; Sayyad Z
    Front Immunol; 2018; 9():1287. PubMed ID: 29951055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optineurin and its mutants: molecules associated with some forms of glaucoma.
    Chalasani ML; Swarup G; Balasubramanian D
    Ophthalmic Res; 2009; 42(4):176-84. PubMed ID: 19672125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A glaucoma-associated mutant of optineurin selectively induces death of retinal ganglion cells which is inhibited by antioxidants.
    Chalasani ML; Radha V; Gupta V; Agarwal N; Balasubramanian D; Swarup G
    Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1607-14. PubMed ID: 17389490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of optineurin siRNA on apoptotic genes and apoptosis in RGC-5 cells.
    Li H; Ao X; Jia J; Wang Q; Zhang Z
    Mol Vis; 2011; 17():3314-25. PubMed ID: 22194658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of decreased OPTN expression on the survival of the rat retinal ganglion cell line RGC5].
    Xu Z; Chen F; Yan H
    Zhonghua Yan Ke Za Zhi; 2014 Aug; 50(8):598-605. PubMed ID: 25385380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution and localization of abnormally expressed OPTN proteins in RGC5 retinal ganglion cells and their effects on subcellular morphology.
    Xu ZR; Jiang FG; Chen F
    Genet Mol Res; 2015 Oct; 14(4):12093-101. PubMed ID: 26505356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpressed mutant optineurin(E50K) induces retinal ganglion cells apoptosis via the mitochondrial pathway.
    Meng Q; Lv J; Ge H; Zhang L; Xue F; Zhu Y; Liu P
    Mol Biol Rep; 2012 May; 39(5):5867-73. PubMed ID: 22422156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of abnormal optineurin expression on the survival of the rat retinal ganglion cell line RGC-5.
    Xu ZR; Jiang FG; Chen F
    Genet Mol Res; 2015 Aug; 14(3):9171-80. PubMed ID: 26345850
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.